Anticoagulants Market (By Route of Administration: Oral , Injectable; By Drug Class: Factor XA Inhibitors (NOAC/DOAC), Heparins, Direct Thrombin Inhibitors, Vitamin K Antagonists; By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies; By Indication: Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Atrial Fibrillation, Heart Attack) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 160


The world-wide Anticoagulants market is expected to garner USD 39 billion by 2026 and the market is expected to register CAGR growth over 7.9% during the next eight years.

Market Dynamics

Growing need for controlling the diseases such as kidney diseases and cardiovascular diseases is expected to propel the market growth over forecast period. In addition to this, rise in obesity patient and hence related disorders is another factor which is ultimately boosting the adoption of Anticoagulants in the healthcare areas and hence driving the market growth.

Market Insights

The worldwide anticoagulants market is anticipated to show significant growth during the forecast period, due to the increasing prevalence of cardiovascular disorders, venous thromboembolism (VTE), and others. Also, increasing adoption of novel oral anticoagulants (NOACs), and rising awareness of NOACs and it’s benefits in the emerging regions are boosting the market growth. The increasing obesity issues and rising population of elderly people, and rise in demand of novel therapeutics are some of the other factors driving the market growth. On the other hand, higher price of NOACs and lack of awareness about the anticoagulants to hamper the market growth.

The anticoagulant are drugs which functions as a blood thinners. The anticoagulants are used for preventing or reducing the coagulation of blood also used to prolong the blood clotting time. These drugs are majorly used for high risk of blood clots in various medical conditions. The importance of anticoagulants in preventing the clot formation in the human body is foreseen to be prime factor driving the market growth. Also, anticoagulants are used in the prevention of enlargement of the existing clots in the vein or arteries so that the health hazards are reduced to significant level.

Such properties of Anticoagulants are making them one of the irreplaceable part in the operational areas associated with the heart attack, stroke, deep venous thrombosis (DVT), pulmonary embolism (PE), angina, dialysis, atrial fibrillation (AF), thrombocytopenia, and myocardial infarction. In addition, anticoagulants plays an outstanding role while performing the surgery.

Market Segmentation

Market By Route of Administration

  • Oral
  • Injectable

Market By Drug Class

  • Factor XA Inhibitors (NOAC/DOAC)
  • Heparins
  • Direct Thrombin Inhibitors
  • Vitamin K Antagonists

Market By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Market By Indication

  • Deep Vein Thrombosis (DVT)
  • Pulmonary Embolism (PE)
  • Atrial Fibrillation
  • Heart Attack

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Regional Insights

In terms of consumption of anticoagulants, the North America was the dominant region in the year 2018 and the similar trend is expected to continue over forecast period due to rapid increase in the surgeries such as hip and knee surgeries in this region. Europe region is following the North America in terms of demand for anticoagulants. Increase in geriatric population is expected to be one of the key factor boosting the demand for anticoagulant in this region.

On the other hand, APAC region is expected to register significant CAGR growth rate over forecast period. Tnhe increasing health issues due to changing lifestyle as well as increasing surgical operations in this region are some of the prime factors accelerating the demand for anticoagulants in this region. Also, increasing network of healthcare facilities is expected to be another factor creating a demand for anticoagulants.

Market Participants

The key players operating in the global anticoagulants market are Bristol-Myers Squibb Company, Pfizer, Inc., Bayer Healthcare, Sanofi, Boehringer Ingelheim International GmbH, Johnson & Johnson Services, Inc., and Daiichi Sankyo Company Limited.

Related Reports

Breastfeeding Accessories Market (By Product: Breastfeeding Pumps, Breast Milk Preparation & Cleaning Products, Nipple Care Products, Baby Scales, Breast Milk Storage & Feeding, Breast Shells, Breast Pads, Other Accessories; By Application: Hospital Grade, Personal Use) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global breastfeeding accessories Market is projected worth US$ 1,470.6 million by 2026 and the market is projected to showcase 10.5% CAGR during the forecast period. The breastfeeding accessories market is driven by a rise in population of working mother, the rise in birth rate and fast-paced lifestyle.

ECG Equipment and Management Systems Market (By Product Type: Holter Monitors, Resting ECG System, Stress ECG Monitors, Event Monitoring Systems, ECG Management Systems; By End Use: Hospitals & Clinics, Ambulatory Facilities, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction ECG Equipment and Management Systems is a gadget which records the heart exercises through electric signals and are enhanced on the ECG screen. ECG Equipment and Management Systems are utilized to analyze sorts of heart illnesses and arrhythmias in an individual's body in this manner help the suitable treatment. The ECG test is noninvasive and effortless method and decides irregularity designs

Macular Degeneration Treatment Market (By Disease Indication: Dry Age-related Macular Degeneration Treatment, Wet Age-related Macular Degeneration Treatment, Others; By Drug Class: Anti-vascular endothelial growth factor, Others; By End-user: Ambulatory Surgical Centers, Hospitals, Ophthalmic Clinics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global macular degeneration treatment Market is estimated to value US$ 11.4 Billion by 2026 and the market is projected to showcase 6.6% CAGR during the forecast period. The macular degeneration treatment market is driven by surge in healthcare spending and improved in healthcare infrastructure. Market D

Gynecological Devices Market (By Device: Surgical Devices [Endoscopy Devices, Fluid Management Systems, Endometrial Ablation Devices, Contraceptive Devices, Others], Diagnostic Imaging Systems [Ultrasound, Mammography, MRI, Others], Hand Held Instruments [Biopsy Forceps, Tenaculum, Curettes, Others], Software, Others; By End-Users: Hospitals, Clinics, Diagnostic Centres, Research Institutes, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global Gynecological Devices market was valued at $9.4 billion in 2018 and is anticipated to grow at a CAGR of 7.9% during the forecast period. Gynecological devices include instruments and devices used for the treatment of diseases related to the female reproductive system. These devices include surgical devices, handheld instruments, diagnostic i

Cart Summary